US BANCORP \DE\ - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 144 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$17,147
-64.4%
1,348
-60.6%
0.00%
Q2 2023$48,210
-27.7%
3,424
-20.7%
0.00%
Q1 2023$66,713
-8.9%
4,318
-3.4%
0.00%
Q4 2022$73,247
-18.6%
4,469
-7.7%
0.00%
Q3 2022$90,000
+69.8%
4,840
+19.4%
0.00%
Q2 2022$53,000
+194.4%
4,052
+100.6%
0.00%
Q1 2022$18,000
-21.7%
2,020
-14.0%
0.00%
Q4 2021$23,000
-66.2%
2,348
+18.5%
0.00%
Q3 2021$68,000
+15.3%
1,981
+22.7%
0.00%
Q2 2021$59,000
-89.4%
1,615
-87.0%
0.00%
-100.0%
Q1 2021$559,000
-21.9%
12,467
-0.6%
0.00%
-50.0%
Q4 2020$716,000
+26.1%
12,543
+13.3%
0.00%
+100.0%
Q3 2020$568,000
+222.7%
11,073
+275.1%
0.00%
Q2 2020$176,000
+112.0%
2,952
+46.6%
0.00%
Q1 2020$83,000
+3.8%
2,013
+56.9%
0.00%
Q4 2019$80,000
+247.8%
1,283
+91.8%
0.00%
Q3 2019$23,0006690.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$69,030,00015.95%
SV Health Investors, LLC 449,951$25,679,00012.37%
Sunesis Advisors, LLC 96,299$5,496,0004.45%
Redmile Group, LLC 4,437,968$253,275,0003.07%
Consonance Capital Management LP 484,671$27,660,0002.58%
SECTORAL ASSET MANAGEMENT INC 488,842$27,898,0001.97%
Opaleye Management Inc. 222,000$12,670,0001.66%
Eversept Partners, LP 246,240$14,052,9171.65%
SILVERARC CAPITAL MANAGEMENT, LLC 38,620$2,204,0001.28%
Avoro Capital Advisors LLC 1,300,000$74,191,0001.28%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders